These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7912803)

  • 1. Hepatitis A virus antibody levels in factor VIII concentrates.
    Wood DJ; Bird CR; Thorpe R; Barrowcliffe TW
    Lancet; 1994 Jul; 344(8916):202-3. PubMed ID: 7912803
    [No Abstract]   [Full Text] [Related]  

  • 2. An outbreak of hepatitis A among Irish haemophiliacs.
    Johnson Z; Thornton L; Tobin A; Lawlor E; Power J; Hillary I; Temperley I
    Int J Epidemiol; 1995 Aug; 24(4):821-8. PubMed ID: 8550281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States?
    Mosley JW
    Vox Sang; 1994; 67 Suppl 4():12-5; discussion 24-6. PubMed ID: 7831863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple and reliable salivary tests for HIV and hepatitis A and B virus diagnosis and surveillance.
    Parry JV
    Ann N Y Acad Sci; 1993 Sep; 694():216-33. PubMed ID: 8215057
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of serum IgG antibodies to hepatitis A virus in Italian haemophiliacs.
    Scaraggi FA; Perricci A; Petronelli M; Lomuscio S; De Mitrio V; Schiraldi O
    Lancet; 1992 Jun; 339(8807):1486-7. PubMed ID: 1351168
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunity to hepatitis A in paediatric and nursery nurses.
    Poole CJ; Shakespeare AT
    Occup Med (Lond); 1996 Oct; 46(5):361-3. PubMed ID: 8918151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody to hepatitis C virus after a vapor heated factor VIII concentrate--lack of evidence.
    Anderle K; Eder G; Eibl J
    Thromb Haemost; 1991 Nov; 66(5):620-2. PubMed ID: 1803628
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the prevalence of IgG antibodies to hepatitis E virus and hepatitis A virus in members of households in the Mekong delta region of Vietnam.
    Kolaitis N
    Am J Trop Med Hyg; 2000 Jan; 62(1):1. PubMed ID: 10761716
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution of hepatitis A antibody over a process for the preparation of a high-purity factor VIII concentrate.
    Hart H; Jones A; Cubie H; McIntosh RV; Cuthbertson B
    Vox Sang; 1994; 67 Suppl 1():51-5. PubMed ID: 8091738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Another success for hepatitis A vaccine.
    Baker CJ
    N Engl J Med; 2007 Oct; 357(17):1757-9. PubMed ID: 17947391
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of immunoglobulin M antibody to hepatitis A virus in patients without acute hepatitis A: the usefulness of specific immunoglobulin G avidity.
    Roque-Afonso AM; Mackiewicz V; Dussaix E
    Clin Infect Dis; 2006 Mar; 42(6):887-8. PubMed ID: 16477569
    [No Abstract]   [Full Text] [Related]  

  • 12. Host immune response to hepatitis A virus.
    Stapleton JT
    J Infect Dis; 1995 Mar; 171 Suppl 1():S9-14. PubMed ID: 7876654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis A virus infection. No conclusive link to factor VIII.
    Prowse C
    BMJ; 1993 Aug; 307(6903):561-2. PubMed ID: 8400989
    [No Abstract]   [Full Text] [Related]  

  • 14. Pasteurized, monoclonal antibody factor VIII concentrate: establishing a new standard for purity and viral safety of plasma-derived concentrates.
    Goldsmith JC
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):203-15. PubMed ID: 10759015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of antibodies against hepatitis A (anti-HAV) in Singapore: the NFDD experience.
    Fock KM; Tay HH; Phua KB; Guan R; Chia SC; Chong R; Chee AE; Chew CN
    Singapore Med J; 1995 Feb; 36(1):26-7. PubMed ID: 7570129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-exposure prophylaxis for hepatitis A: immune globulin, vaccine or both?
    Allam MF
    J Prev Med Hyg; 2008 Dec; 49(4):129-30. PubMed ID: 19350959
    [No Abstract]   [Full Text] [Related]  

  • 17. Approaching the ideal: therapeutic requirements for factor VIII concentrates.
    Vermylen J
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S36-9. PubMed ID: 7495966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination against hepatitis A].
    Zamir D; Zamir H; Weiner P
    Harefuah; 1998 Aug; 135(3-4):114-8. PubMed ID: 9885656
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis A vaccine versus immunoglobulin for post-exposure prophylaxis.
    Srivastava A; Aggarwal R
    Natl Med J India; 2007; 20(6):302-3. PubMed ID: 18335798
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis A virus sequence detected in clotting factor concentrates associated with disease transmission.
    Robertson BH; Alter MJ; Bell BP; Evatt B; McCaustland KA; Shapiro CN; Sinha SD; Souci JM
    Biologicals; 1998 Jun; 26(2):95-9. PubMed ID: 9811512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.